Pfizer begins testing omicron-matched COVID shots in adults

(AP) — Pfizer and BioNTech have begun studying a COVID-19 vaccine tweaked to match to the omicron variant in healthy adults.

COVID-19 vaccine makers have been updating their shots in case global health authorities decide a change is needed.

The study announced Tuesday will include more than 1,400 volunteers ages 18 to 55.

Most already are vaccinated and will get boosters of the omicron-based vaccine or the original version.

Some unvaccinated volunteers will get three omicron-based doses.

The original vaccines still offer good protection against severe illness and death.

And a booster improves the chances of avoiding even a milder infection.

To read more on this story, click here.

For more stories across the U.S., click here.